학술논문

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
Document Type
Article
Source
In: Neoplasia (United States). (Neoplasia (United States), September 2017, 19(9):661-671)
Subject
Language
English
ISSN
14765586
15228002